Ten Research Groups promote and support the Division’s portfolio of grants and contracts to external investigators, and conduct original research. Investigators supported by the Division are generating new information about molecular processes that are vulnerable to interventions; developing effective chemoprevention agents; discovering early detection biomarkers; pinpointing mechanistically targeted nutrients; testing new screening methods and technologies; and conducting phase I, II and III clinical trials in prevention and control through national networks and at the community level.
Supports research in biostatistical, clinical trial, and epidemiological methodologies and mathematical modeling of processes relevant to cancer prevention.
Breast and Gynecologic Cancer
Prevention and early detection of breast, cervix, endometrial and ovarian cancers and their precursors.
Research to identify, develop and validate biomarkers for early cancer detection and risk assessment.
Chemopreventive Agent Development
Research on early chemopreventive agent development, from preclinical studies to phase I clinical trials.
Community Oncology and Prevention Trials
Clinical oncology trials in cancer prevention and control in community settings.
Research on the effectiveness and clinical impact of early detection technologies and practices.
Gastrointestinal and Other Cancers
Prevention and early detection of colorectal, esophageal, liver, pancreas and hematolymphoid cancers.
Lung and Upper Aerodigestive Cancer
Conducts and supports research on the prevention and early detection of lung and head and neck cancers.
Understanding how diet and food components affect cancer risk and tumor cell behavior.
Prostate and Urologic Cancer
Conducts and supports research on the prevention and early detection of prostate, bladder, and skin cancers.